By Drug Target Review2024-05-23T12:00:22
This is the first study to demonstrate that a specific set of HERVs expressed in the human brain contribute to disorders like schizophrenia.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-30T09:54:00Z
2024-05-10T11:23:31
Sponsored by BellBrook Labs
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2024-05-07T13:11:19
Sponsored by BellBrook Labs
Site powered by Webvision Cloud